Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Abacus Bidco Oy (which is the parent company of Accountor Software recently acquired by KKR) in the acquisition of certain subsidiaries and assets of 24SevenOffice Group AB (“24SevenOffice”)
Mandate

Vinge advises Abacus Bidco Oy (which is the parent company of Accountor Software recently acquired by KKR) in the acquisition of certain subsidiaries and assets of 24SevenOffice Group AB (“24SevenOffice”)  

November 13, 2024 M&A Capital Markets and Public M&A

24SevenOffice is a listed company (First North Stockholm) that provides modular software for accounting, ERP and business services that automate processes using AI.

The transaction primarily relates to ERP-related subsidiaries and assets, including 24SevenOffice Norway AS, 24SevenOffice Scandinavian Systems and 24SevenOffice Sweden AB. Following completion of the transaction, the acquired assets and subsidiaries will be integrated with Accountor Software.

The purchase price for the ERP-related subsidiaries and assets corresponds to an enterprise value of approximately SEK 2.4 billion.

The transaction is subject to approval by the shareholders of 24SevenOffice and regulatory approval.

Vinge's team consisted primarily of Christina Kokko, Matthias Pannier, Gustav Persson and Ian Linde (M&A), Sofie Bjärtun and Joel Magnusson (Capital Markets and Public M&A), Johan Gavelin (IP), Alice Göransson (Employment), Madelene Andersson (Real Estate), Daniel Wendelsson (FDI), Christoffer Nordin and Katja Häglund (Commercial Agreements), Nicklas Thorgerzon (IT and GDPR), Calle Tengwall Pagels and William Carlberg Johansson (Banking and Finance), Caroline Krassén (Financial Services), Caroline Löv and Filippa Bergkvist (Transaction Support).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025